A , B , C , D , E , F , G , H , I , J , K , L , M , N , O , P , Q , R , S , T , U , V , W , X , Y , Z
Kürzel | Test | Einh. | Normalbereich | Hinweis | ||
HSV | H.simplex 1/2 IgG | - | MATERIAL: Serum/Vollblut, METHODE: ELISA | |||
HSVM | H.simplex 1/2 IgM | - | MATERIAL: Serum/Vollblut, METHODE: ELISA | |||
HSV1PCR | H.simplex 1 DNA (PCR) | - | MATERIAL: EDTA, METHODE: PCR | |||
HSV2PCR | H.simplex 2 DNA (PCR) | - | MATERIAL: EDTA, METHODE: PCR | |||
HSV2G | H.simplex 2 IgG | - | MATERIAL: Serum/Vollblut, METHODE: ELISA | |||
H1N1v | H1N1v-RNA (PCR) | - | MATERIAL: Serum/Vollblut, METHODE: PCR | |||
HAEMBAK | Haem.influenzae Typ B IgG | mg/l | - | MATERIAL: Serum/Vollblut | ||
HALO | Haloperidol | ng/ml | 1.000 | - | 10.000 | MATERIAL: Serum/Vollblut, METHODE: LD-MS |
HK | Hämatokrit | % | 37.00 | - | 54.00 | MATERIAL: EDTA, |
HFE | Hämochromatosescreening | - | MATERIAL: EDTA, METHODE: PCR | |||
HB | Hämoglobin | g/dl | 12.00 | - | 18.00 | MATERIAL: EDTA, |
HBEPA | Hämoglobin A | % | - | MATERIAL: EDTA, METHODE: Elektrophorese | ||
HBA1 | Hämoglobin A1c | % | 4.80 | - | 5.90 | MATERIAL: EDTA, METHODE: CMIA |
HBA1M | Hämoglobin A1c (IFCC) | mmol/mol | 29.00 | - | 39.00 | MATERIAL: EDTA, METHODE: CMIA |
HBA1CALC | Hämoglobin A1c (IFCC) | mmol/mol | 29.0 | - | 40.0 | MATERIAL: EDTA-Blut, METHODE: |
HBEPA2 | Hämoglobin A2 | % | - | MATERIAL: EDTA, METHODE: Elektrophorese | ||
HBEPF | Hämoglobin F | % | - | MATERIAL: EDTA, METHODE: Elektrophorese | ||
HÄMOPEXIN | Hämopexin | g/l | 0.500 | - | 1.150 | MATERIAL: Serum/Vollblut, METHODE: nephelometrisch |
HANTAG | Hantavirus IgG | - | MATERIAL: Serum; Methode: EIA | |||
HANTBLOTG | Hantavirus IgG-Ak (Blot) | - | MATERIAL: Serum/Vollblut, METHODE: Immunoblot | |||
HANTAM | Hantavirus IgM | - | MATERIAL: Serum; Methode: EIA | |||
HANTBLOTM | Hantavirus IgM-Ak (Blot) | - | MATERIAL: Serum/Vollblut, METHODE: Immunoblot | |||
HAPTO | Haptoglobin | mg/dl | 30.0 | - | 200.0 | MATERIAL: Serum/Vollblut, METHODE: Immunologischer Trübungstest |
HPATH | Harn auf pathogene Keime | - | MATERIAL: Spontanharn, METHODE: Kultur | |||
HBILI | Harnbilirubin | mg/dl | - | MATERIAL: Spontanharn, METHODE: STIX | ||
HEW | Harneiweiß | mg/dl | - | MATERIAL: Spontanharn, METHODE: STIX | ||
HARN | Harn komplett | - | ||||
TBCH | Harnkultur auf Tbc | - | MATERIAL: Spontanharn, METHODE: Kultur | |||
HSR | Harnsäure | mg/dl | 2.00 | - | 7.20 | MATERIAL: Serum/Vollblut, METHODE: photometrisch |
HSRU | Harnsäure i.Harn | mg/dl | - | MATERIAL: Spontanharn, METHODE: photometrisch | ||
HSRH | Harnsäure im 24h-Harn | mg/24h | 0.0 | - | 800.0 | MATERIAL: 24h-Sammelharn, METHODE: photometrisch |
HSRP | Harnsäure im Punktat | mg/dl | 2.00 | - | 7.00 | MATERIAL: Punktat, METHODE: photometrisch |
SED | Harnsediment | - | MATERIAL: Spontanharn, METHODE: Mikroskopie | |||
STATH | Harnstatus | - | MATERIAL: Harn, METHODE: STIX | |||
HST | Harnstoff | mg/dl | 18.0 | - | 50.0 | MATERIAL: Serum/Vollblut, METHODE: photometrisch |
HZ | Harnzucker | mg/dl | 0.0 | - | 499.0 | MATERIAL: Spontanharn, METHODE: STIX/photometrisch |
HAV | HAV - Antikörper (IgG) | - | MATERIAL: Serum/Vollblut, METHODE: MEIA | |||
HAVM | HAV - Antikörper (IgM) | - | MATERIAL: Serum/Vollblut, METHODE: MEIA | |||
HAVPCR | HAV - RNA (PCR) | - | MATERIAL: Serum/Vollblut, METHODE: PCR | |||
HBCAK | HBc - Antikörper (IgG) | - | MATERIAL: Serum/Vollblut, METHODE: MEIA | |||
HBCM | HBc - Antikörper (IgM) | - | MATERIAL: Serum/Vollblut, METHODE: MEIA | |||
HBEAG | HBe - Antigen | - | MATERIAL: Serum/Vollblut, METHODE: MEIA | |||
HBEAK | HBe - Antikörper | - | MATERIAL: Serum/Vollblut, METHODE: MEIA | |||
HBELPH | Hb-Elektrophorese | - | MATERIAL: EDTA, METHODE: Elektrophorese | |||
HBEPTX | HB Elphor Beurteilung: | - | MATERIAL: EDTA, METHODE: Elektrophorese | |||
HBSAGbest | HBsAg-Bestätigungstest | - | MATERIAL: Serum/Vollblut, METHODE: MEIA | |||
HBSAG | HBs - Antigen | - | MATERIAL: Serum/Vollblut, METHODE: MEIA | |||
HBSAK | HBs - Antikörper | mIU/ml | - | MATERIAL: Serum/Vollblut, METHODE: MEIA | ||
HCG | HCG | mIE/ml | 0.00 | - | 5.00 | MATERIAL: Serum/Vollblut, METHODE: MEIA |
HCV | HCV-AK (IgG+IgM) | - | MATERIAL: Serum/Vollblut, METHODE: MEIA | |||
HCVBEST | HCV-AK (IgG Bestätigung) | - | MATERIAL: Serum/Vollblut, METHODE: MEIA | |||
HCVGENO | HCV - Genotyp | - | MATERIAL: Serum/Vollblut, METHODE:LiPA | |||
HCVPCR | HCV - RNA (PCR) | - | MATERIAL: Serum/Vollblut, METHODE: PCR | |||
HDL | HDL-Cholesterin | mg/dl | 40.0 | - | 68.0 | MATERIAL: Serum/Vollblut, METHODE: photometrisch |
HDVSCREEN | HDV-Antikörper (IgG + IgM) | - | MATERIAL: Serum/Vollblut | |||
HDVG | HDV IgG Antikörper | - | MATERIAL: Serum/Vollblut | |||
HDVM | HDV IgM Antikörper | - | MATERIAL: Serum/Vollblut | |||
HDVPCR | HDV - RNA (PCR) | - | MATERIAL: Serum/Vollblut | |||
HE4 | HE4 (Hum.Epidid.Prot.4) | pmol/l | 0.00 | - | 104.00 | MATERIAL: Serum/Vollblut, METHODE: MEIA |
HEINZ | Heinz'sche Innenkörper | - | MATERIAL: EDTA, METHODE: Mikroskopie | |||
CD4_8 | Helfer-Suppressor Ratio | 1.200 | - | 2.500 | MATERIAL: EDTA-Blut, METHODE: Flow cytometrie | |
HLPABS | Helferzellen absolut | /mm3 | 410.0 | - | 1590.0 | MATERIAL: EDTA, METHODE: Flow cytometrie |
HLPREL | Helferzellen relativ | % | 29.0 | - | 58.0 | MATERIAL: EDTA-Blut, METHODE: Flow cytometrie |
HPYLST | Helicobacter pyl.AG im Stuhl | - | MATERIAL: Stuhl, METHODE: ELISA | |||
HPYL | Helicobacter pylori IgG | U/ml | 0.000 | - | 0.890 | MATERIAL: Serum/Vollblut, METHODE: LIA |
HAVQUANT | Hep.A Impftiter | - | MATERIAL: Serum/Vollblut, METHODE: MEIA, | |||
HBSQUANT | Hep.B Impftiter | mIU/ml | - | MATERIAL: Serum/Vollblut, METHODE: MEIA | ||
HSS | Hep.B-Serologie | - | ||||
HIT | Hep.-induz. Thrombozytopenie | - | ||||
PF4AK | Heparin/PF4 AK (HIT) | - | MATERIAL: Serum Methode:ELIA | |||
HIPA | Heparin induz. Plättchenaggreg. | - | MATERIAL: Serum, METHODE: HIPA-Test | |||
HBVPCRVL | Hepatitis B PCR Viral load | IU/ml | 0.0 | - | 10.0 | MATERIAL: Serum, METHODE: PCR |
HCVPCRVL | Hepatitis C PCR Viral load | IU/ml | - | MATERIAL: Serum, METHODE: PCR | ||
FRUCTGEN | Hered.Fruktoseintoleranz(HFI) | - | MATERIAL: EDTA; Methode: Gentest | |||
LAKTGEN | Hered.Laktoseintoleranz (LCT) | - | MATERIAL: EDTA; Methode: Gentest | |||
HEROINH | Heroin/6-AM (U) | - | MATERIAL: Spontanharn, METHODE: CEDIA | |||
HMA | Herzmuskel-AK | Titer | 0.0 | - | 100.0 | MATERIAL: Serum/Vollblut |
HEVG | HEV-Ak IgG | - | MATERIAL: Serum/Vollblut, METHODE: MEIA | |||
HEVM | HEV-Ak IgM | - | MATERIAL: Serum/Vollblut, METHODE: MEIA | |||
HEVPCR | HEV - RNA (PCR) | - | MATERIAL: Serum/Vollblut, METHODE: PCR | |||
LINDAN | Hexachlorcyclohexan (Lindan) | ug/l | < | 0.100 | MATERIAL: Spezialröhrchen, METHODE: GC-MS | |
HGH | HGH/STH | µg/l | 0.000 | - | 13.400 | MATERIAL: Serum/Vollblut, METHODE: LIA |
HSU | Hippursäure i.Harn | mg/l | 0.0 | - | 1500.0 | MATERIAL: Spontanharn, METHODE: HPLC |
HISTF | Histamin | ug/l | < | 1.980 | MATERIAL: EDTA-Plasma | |
HISTO | Histologischer Befund | - | MATERIAL: Gewebeprobe | |||
HIV | HIV 1/2 AG/AK (Suchtest) | - | MATERIAL: Serum/Vollblut, METHODE: MEIA | |||
HIVMKP | HIV 1/2 AG/AK MKP | - | MATERIAL: Serum/Vollblut, METHODE: MEIA | |||
HIVZWEIT | HIV 1/2 Ak (Zweittest) | - | MATERIAL: Serum/Vollblut ;METHODE:CMIA | |||
HIVAGBEST | HIV 1 Antigen (Referenztest) | - | MATERIAL: Serum/Vollblut ;METHODE:CMIA | |||
HIVAG | HIV 1 Antigen (Suchtest) | - | MATERIAL: Serum/Vollblut ;METHODE:CMIA | |||
HIVAKBLOT | HIV Ak BLOT (Referenztest) | - | MATERIAL: Serum/Vollblut ;METHODE:CMIA | |||
HIVPCRVL | HIV PCR Viral load | Kopien/ml | - | MATERIAL: EDTA , Methode: PCR | ||
HIVRES | HIV Resistenz | - | MATERIAL: EDTA, | |||
HLAB27G | HLA B27 molekulargen.Typ | - | MATERIAL: EDTA, | |||
HLAB27 | HLA B27 Screening | - | MATERIAL: EDTA, METHODE: Durchflusszytometrie | |||
HLAB51 | HLA B51 | - | MATERIAL: EDTA, METHODE: SSO (spezielle PCR) | |||
HLADQ2 | HLADQ2 | - | MATERIAL: EDTA, METHODE: PCR | |||
HLADQ7 | HLADQ7 | - | MATERIAL: EDTA, METHODE: | |||
HLADQ8 | HLADQ8 | - | MATERIAL: EDTA, METHODE: PCR | |||
HOLOTC | Holotranscobalamin | pmol/l | 37.50 | - | 188.00 | MATERIAL: Serum/Vollblut, METHODE: MEIA |
HOMA | HOMA - Index | - | ||||
HOCY | Homocystein | umol/l | 0.00 | - | 12.00 | MATERIAL: Serum/Vollblut, METHODE: MEIA |
HVSH | Homovanillinsäure | mg/24h | 1.82 | - | 6.92 | MATERIAL: 24h-Sammelharn angesäuert, METHODE: HPLC |
HUMANFGF23 | Humanes FGF-23-c-terminal | kRU/l | 26.00 | - | 110.00 | MATERIAL: EDTA-Blut; METHODE: ELISA |
HHV6G | Humanes Herpesvirus 6 IgG | - | MATERIAL: Serum/Vollblut, METHODE: ELFA | |||
HHV6M | Humanes Herpesvirus 6 IgM | - | MATERIAL: Serum/Vollblut, METHODE: ELFA | |||
HHV8G | Humanes Herpesvirus Typ 8 IgG | - | MATERIAL: Serum/Vollblut, METHODE: ELFA | |||
IMMUNSHUM | Humoraler Immunstatus | - | MATERIAL: Serum/Vollblut | |||
CHLOROQUIN | Hydrochloroquin | ug/l | - | MATERIAL: Serum, METHODE: LC-MS | ||
HYDROMORPH | Hydromorphon | ug/l | 5.0 | - | 15.0 | MATERIAL: Serum; Methode: LC-MS |
BUPRO_OH | Hydroxybupropion | ug/l | - | MATERIAL: Serum, METHODE: LC-MS | ||
HPROLIN | Hydroxyprolin | umol/l | 0.0 | - | 50.0 | MATERIAL:Serum/Vollblut,spez.Präanalytik!METHODE:HPLC |
HPROLINH | Hydroxyprolin (24h-Harn) | mmol/molK | 0.000 | - | 13.000 | MATERIAL: 24h Harn, METHODE: HPLC |
HYDROXYZIN | Hydroxyzin | ng/ml | 30.00 | - | 90.00 | MATERIAL: Serum; METHODE: LC-MS |
MTHFR | Hyperhomocysteinämie | - | MATERIAL: EDTA, Methode: Gentest |